GORD and GLP-1 receptor agonists: an emerging concern for gastroenterologists
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GORD and GLP-1 receptor agonists: an emerging concern for gastroenterologists
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2023-331027
Publisher
BMJ
Online
2023-11-03
DOI
10.1136/gutjnl-2023-331027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
- (2023) Sean Wharton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide
- (2023) Marc Sherwin et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study
- (2023) Benjamin Douglas Liu et al. GUT
- Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy
- (2023) Saullo Queiroz Silveira et al. Journal of Clinical Anesthesia
- The role of gastric function in control of food intake (and body weight) in relation to obesity, as well as pharmacological and surgical interventions
- (2023) Michael Camilleri NEUROGASTROENTEROLOGY AND MOTILITY
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- (2023) Mikhail N. Kosiborod et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
- (2023) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial
- (2022) Daniel Maselli et al. Obesity
- Weight and Health — Pathophysiology and Therapies
- (2022) Louis J. Aronne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
- (2022) Lulu Liu et al. Frontiers in Endocrinology
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reflux Symptoms in Gastroparesis
- (2019) Asad Jehangir et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The contribution of obesity to prescription opioid use in the United States
- (2019) Andrew Stokes et al. PAIN
- Weight Loss as a Nonpharmacologic Strategy for Erosive Esophagitis: a 5-Year Follow-up Study
- (2018) Ki Bae Bang et al. Gut and Liver
- Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment
- (2017) Asad Jehangir et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis
- (2015) Xiao-Meng Sun WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now